Adam S. Mostafa
2020
In 2020, Adam S. Mostafa earned a total compensation of $1.2M as Chief Financial Officer and Treasurer at X4 Pharmaceuticals, a 36% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $163,600 |
|---|---|
| Salary | $400,000 |
| Stock Awards | $612,950 |
| Other | $564 |
| Total | $1,177,114 |
Mostafa received $613K in stock awards, accounting for 52% of the total pay in 2020.
Mostafa also received $163.6K in non-equity incentive plan, $400K in salary and $564 in other compensation.
Rankings
In 2020, Adam S. Mostafa's compensation ranked 7,926th out of 13,090 executives tracked by ExecPay. In other words, Mostafa earned more than 39.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,926 out of 13,090 | 39th |
Division Manufacturing | 3,365 out of 5,624 | 40th |
Major group Chemicals And Allied Products | 1,361 out of 2,257 | 40th |
Industry group Drugs | 1,183 out of 1,957 | 40th |
Industry Biological Products, Except Diagnostic Substances | 280 out of 411 | 32nd |
Source: SEC filing on April 20, 2021.
Mostafa's colleagues
We found two more compensation records of executives who worked with Adam S. Mostafa at X4 Pharmaceuticals in 2020.
News
X4 Pharmaceuticals CEO Paula Ragan's 2022 pay jumps 81% to $3.9M
April 25, 2023
X4 Pharmaceuticals CEO Paula Ragan's 2021 pay slips 15% to $2.1M
April 25, 2022
X4 Pharmaceuticals CEO Paula Ragan's 2020 pay rises 1% to $2.5M
April 20, 2021
X4 Pharmaceuticals CEO Paula Ragan's 2019 pay jumps 171% to $2.5M
April 28, 2020
X4 Pharmaceuticals CEO René BCPS' 2018 pay jumps 188% to $3.4M
May 22, 2019